The Journal of Addiction Medicine Publishes Patient-centered Outcomes from the Phase 3 Study of SUBLOCADE™ (Buprenorphine Extended-Release) Injection in Patients with Moderate to Severe Opioid Use Disorder (OUD) - MENAFN.COM

Submitted by Anonymous (not verified) on Thu, 03/07/2019 - 16:36

The Journal of Addiction Medicine Publishes Patient-centered Outcomes from the Phase 3 Study of SUBLOCADE™ (Buprenorphine Extended-Release) Injection in Patients with Moderate to Severe Opioid Use Disorder (OUD)  MENAFN.COM(MENAFN - PR Newswire) SLOUGH, England and RICHMOND, Va., March 7, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication ...